Serum level of C-reactive protein and interleukin-6 in children with drug-resistant epilepsy
There is increasing evidence that chronic inflammation affects the pathophysiology of epilepsy, especially the drug-resistant type. Drug-resistant epilepsy is a challenging condition, because of the difficulties in its management, and its unclear epileptogenesis. This study is looking at C-reactive...
Main Authors: | Mohamed M Elwan, Nirmeen A Kishk, Rasha A El-Kapany, Ibrahim E Al-Ahmer, Ahmed Elkady |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-11-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/2058739218808165 |
Similar Items
-
Neuropsychological performance in patients with focal drug-resistant epilepsy and different factors that affect their performance
by: Nirmeen A. Kishk, et al.
Published: (2022-07-01) -
Impact of COVID-19 vaccination in patients with epilepsy
by: Haidy Elshebawy, et al.
Published: (2024-12-01) -
Serum C-Reactive Protein and Interleukin6 Levels in Neonatal Sepsis
by: Dilara Içağasioğlu, et al.
Published: (2002-01-01) -
Measurement of Interleukine-6 and C-reactive Protein in Serum of Patients on Amlodipine Therapy
by: Nahla O. TawÀk, et al.
Published: (2015-08-01) -
Serum Level of Interleukin 6 in Children with Febrile Seizures
by: Mohamed Ahmed, et al.
Published: (2023-11-01)